Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system

Abstract

These data suggest that the CXCR4 promoter has an ideal 'breast cancer-on/liver-off' profile, and could, therefore, be a powerful tool in Ad vector based gene therapy or virotherapy of the carcinoma of the breast.